10-Q · May 14, 2026
Falcon’s Beyond reported significant growth in Q4 2026 with revenue totaling $6,585,000, a 207% increase compared to $1,708,000 in the same period last year, alongside net income of $6,121,000 compared to a loss of…
Earnings analysis · 10-Q
Filed August 13, 2026 · Our reading of the company's report
The latest report
Falcon’s Beyond reported Q2 revenue of $5.618 million and diluted EPS of negative $0.01; revenue increased approximately 12% sequentially and 87% year over year, but EPS declined from $0.05 in Q1 2026 and $0.30 in Q2…
Falcon’s Beyond reported Q2 revenue of $5.618 million and diluted EPS of negative $0.01; revenue increased approximately 12% sequentially and 87% year over year, but EPS declined from $0.05 in Q1 2026 and $0.30 in Q2 2025. The quarter benefited from a $4.0 million legal-accrual reversal, while the $11.1 million Guggenheim dispute remains reasonably possible and could materially affect future results. Sentiment is neutral because revenue momentum and legal-accounting relief are offset by continuing losses, no quantitative guidance, persistent material weaknesses across five control areas, and unresolved litigation.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Q2 revenue was $5.618 million, up from $5 million in Q1 2026 and $3 million in Q2 2025, representing approximately 12% sequential growth and 87% year-over-year growth.
Management reversed $4.0 million of a previously recorded Business Combination-related accrual during the quarter, reducing reported contingent-liability exposure.
The company previously reversed an $11.1 million Guggenheim-related accrual in Q1 2026 after concluding that a loss was no longer probable, although the matter remains unresolved.
The Guggenheim litigation will proceed to trial after the court granted Guggenheim’s motion in part, denied the company’s motion, and allowed certain company counterclaims to proceed.
The filing states that five categories of previously reported internal-control material weaknesses—Risk Assessment, Control Activities, Monitoring, Control Environment, and Information and Communication—continued to exist as of June 30, 2026.
Disclosure controls and procedures were not effective as of June 30, 2026 because of continuing material weaknesses in internal control over financial reporting. The filing identifies five affected control areas and says remediation remains in process.
Although no accrual remains for the Guggenheim matter, management characterizes the risk of loss as reasonably possible and says an adverse outcome could materially affect financial condition, results of operations, or cash flows. The underlying claim is for $11.1 million.
The company reversed $4.0 million of a previously recorded Business Combination-related accrual, but states that the ultimate outcome remains uncertain and that no estimate of possible loss or range of loss can currently be made.
No quantitative revenue or EPS guidance was provided in the supplied filing materials. Management stated it remains confident in building on Attractions momentum; outlook was otherwise deferred to the earnings release/call.
Falcon’s Beyond reported significant growth in Q4 2026 with revenue totaling $6,585,000, a 207% increase compared to $1,708,000 in the same period last year, alongside net income of $6,121,000 compared to a loss of…
Falcon’s Beyond’s 10-K emphasizes a platform strategy focused on growing FCG and FBB while moving FBD to a more asset‑efficient model. The company reported Q4 2025 revenue of $7.0 million with a gross margin of 69.5%…
Falcon’s Beyond reported Q3 revenue of $4.054M, up from $2.069M a year ago and $3.0M in the prior quarter, while GAAP diluted EPS was a loss of $0.13. Operating margin improved to -90.9% from -119.0% in 2024Q3, but the…
Falcon’s Beyond reported revenue of $1,708,000 for the quarter ended March 31, 2025, up from $1,516,000 year-over-year, but recorded a GAAP net loss of $8,092,000 (net loss per diluted share $0.13). Operating loss…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.